Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Latest filing published 01 Sept 2026 for Abeona Therapeutics INC., €76k. Read the official filing
Filing timeline
BuySaleMark Alvino
Insider track record
Disclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Alvino: trading record in brief
Mark Alvino is a declared insider of Abeona Therapeutics Inc. (board member), with filings sourced from SEC (Form 4). We count 24 filings; the first trade dates from 25 May 2021 and the latest from 1 September 2026.
Every open-market trade on record is a sale: 16 sales worth €570k. Besides market trades, the filings include 7 share grants. 2026 to date brings no purchases and 4 sales.
The latest filing, published on 1 September 2026, reports an open-market sale of €76k in Abeona Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Alvino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
15,000 shares@ US$5.86440.026% mcap9.2% of flowCommon StockSEC:0001493152-26-041068:0
500 shares0Common StockSEC:0001493152-26-025258:0
6,500 shares@ US$5.45580.011% mcap5.6% of flowCommon StockSEC:0001493152-26-025085:0
2,000 shares@ US$5.09061.2% of flowCommon StockSEC:0001493152-26-004759:0
37,313 shares0Common StockSEC:0001493152-26-003804:0
13,500 shares@ US$5.22778.1% of flowCommon StockSEC:0001493152-26-003094:0
15,000 shares@ US$4.74459.1% of flowCommon StockSEC:0001493152-25-023532:0
13,093 shares@ US$5.855710.6% of flowCommon StockSEC:0001641172-25-018599:0
2,000 shares@ US$6.382.1% of flowCommon StockSEC:0001641172-25-012556:0
8,000 shares@ US$5.687.4% of flowCommon StockSEC:0001641172-25-011289:0
36,101 shares0Common StockSEC:0001493152-25-004749:0
4,000 shares@ US$5.383.8% of flowCommon StockSEC:0001493152-25-004437:0
4,000 shares@ US$5.103.6% of flowCommon StockSEC:0001493152-25-003052:0
11,797 shares0Common StockSEC:0001493152-24-034050:0
23,611 shares0Common StockSEC:0001493152-24-026644:0
25,890 shares@ US$4.5119.8% of flowCommon StockSEC:0001493152-24-024528:0
7,084 shares@ US$5.116.1% of flowCommon StockSEC:0001493152-24-003193:0
6,316 shares@ US$3.91458.3% of flowCommon StockSEC:0001493152-23-034856:0
58,689 shares@ US$4.6245.6% of flowCommon StockSEC:0001493152-23-021652:0
887 shares@ US$3.250.5% of flowCommon StockSEC:0001493152-23-015587:0
13,400 shares0Common StockSEC:0001493152-22-027042:0
20,000 shares@ US$0.15490.4% of flowCommon StockSEC:0001493152-22-017168:0
35,000 shares@ US$0.15610.7% of flowCommon StockSEC:0001493152-22-016079:0
77,181 shares0Common StockSEC:0001493152-21-013118:0
24 of 24 declarations
